Get Quote
👁️ STERILE OPHTHALMIC PACKAGING SOLUTION

Eye Drops Blister Packaging Machine
Sterile · Preservative-Free · 0.3-1ml

Class 100 cleanroom compatible single-dose ophthalmic packaging. Eliminates BAK preservatives causing 30% irritation. EU GMP Annex 1 compliant.

Class 100 / ISO 5 Sterile Filling Preservative-Free EU GMP Annex 1 Ophthalmic Grade
Sterile Eye Drops Blister Packaging Machine - HIJ
cGMP
Annex 1
ISO 5
WHO PQ

HIJ Eye Drops Blister Machine — Quick Facts

Sterile ophthalmic packaging specifications

HIJ eye drops blister packaging machines are sterile ophthalmic-grade unit-dose packaging systems manufactured in Wenzhou, China. Designed specifically for preservative-free eye drops, ophthalmic solutions, glaucoma medications, antibiotic eye drops, and post-surgical eye care products. Filling range 0.3ml to 1ml per cavity with ±1% accuracy at 300-400 units per minute. Compatible with Class 100 (ISO 5) cleanroom environments, isolator/RABS configurations, and full compliance with EU GMP Annex 1 (2022 revision), cGMP 21 CFR 210/211, USP <771> ophthalmic preparations, USP <1207> container closure integrity, and WHO TRS 961. Each unit-dose blister maintains 24-month sterility without preservatives, eliminating the BAK irritation suffered by 30% of multi-dose eye drops users.

Filling Range 0.3–1ml per cavity
Filling Accuracy ±1% (USP <905> compliant)
Production Speed 300–400 units/min
Cleanroom Class Class 100 / ISO 5 compatible
Sterility 24-month maintained
Preservative-Free Yes, with isolator
EU GMP Compliance Annex 1 (2022) ready
Lead Time 16–22 weeks (FOB Wenzhou)

Multi-Dose Bottles vs Unit-Dose Eye Drop Blisters

Why ophthalmic regulators worldwide prefer unit-dose format

The Multi-Dose Eye Drops Crisis

30% of patients experience irritation from BAK preservatives. 50-70% of bottle content wasted due to 28-day post-opening sterility limits. Unit-dose blisters solve both problems.

Multi-Dose Eye Drop Bottles

Traditional format with growing safety concerns

BAK Preservative Irritation 30% of users experience burning, redness, dry eye worsening
50-70% Product Waste 28-day post-opening limit forces patients to discard most bottle
Cross-Contamination Risk Bottle tip touches eye/eyelid → introduces bacteria back into bottle
Inaccurate Dosing Drop size varies 25-56μl depending on bottle squeeze technique
Not for Post-Surgical Use FDA prohibits multi-dose for cataract/LASIK post-op care
Travel Storage Issues Once opened, requires careful storage; airline restrictions apply

HIJ Unit-Dose Blister Eye Drops

Modern preservative-free standard of care

Zero Preservatives Possible Sealed unit-dose eliminates need for BAK or any preservative
100% Product Used Every blister = full sterile dose, no waste, full shelf life until opening
Sterile Per Application Each dose sealed sterile until moment of use — zero contamination
Precise Dosing ±1% 0.3-1ml exact prescribed volume — no squeeze variability
Post-Surgical Approved Standard of care for cataract, LASIK, glaucoma surgery recovery
Travel-Friendly TSA-compliant individual doses, no liquid restrictions

Switching from Multi-Dose to Unit-Dose Eye Drops?

Get a free regulatory pathway analysis for your formulation transition

Request Analysis

Sterile Filling System for Ophthalmic Drugs

Class 100 (ISO 5) compatible aseptic processing technology

HIJ Sterile Eye Drops Filling Station with Precision Nozzles

Isolator / RABS Configuration

Restricted Access Barrier System or full isolator with VHP decontamination provides Grade A air over open product per EU GMP Annex 1.

Class 100 / ISO 5

HEPA Filtration System

Triple HEPA filtration (H14 grade, 99.995% efficiency at 0.3μm) maintains continuous Grade A environment during entire filling cycle.

H14 HEPA filters

0.22μm Sterile Filtration

Ophthalmic solution sterile-filtered through 0.22μm membrane immediately before filling. Bubble point integrity testing per USP <788>.

0.22μm filtration

VHP Decontamination Cycle

Vaporized hydrogen peroxide decontamination achieves 6-log sporicidal reduction. Validated cycle ≤45 minutes for production turnaround.

6-log SAL

Continuous Particle Monitoring

Integrated viable and non-viable particle counters per Annex 1 (2022). Real-time alarm for excursions. Full data integrity per 21 CFR Part 11.

Continuous monitoring

Aseptic Process Simulation

Media Fill protocols included per FDA Aseptic Processing Guide. Validates aseptic capability with ≤1 contaminated unit per 5,000-10,000 unit fill.

Media Fill ready

Ophthalmic Applications & Drug Categories

Validated formulations for sterile unit-dose ophthalmic packaging

ARTIFICIAL TEARS

Artificial Tears & Lubricants

DRY EYE · LUBRICATION · COMFORT

Carboxymethylcellulose (CMC), hyaluronic acid, hydroxypropyl methylcellulose (HPMC), polyethylene glycol artificial tears for dry eye syndrome.

Volume:0.4-0.6ml per dose
Production:350-400/min
Format:Strip of 30-60 doses
Shelf Life:24 months sterile
Preservative-Free High Volume OTC Format
GLAUCOMA

Glaucoma Medications

PRESCRIPTION · LONG-TERM USE

Prostaglandin analogs (latanoprost, travoprost), beta-blockers (timolol), carbonic anhydrase inhibitors. Daily long-term use makes preservative-free critical.

Volume:0.3-0.4ml per dose
Production:300-380/min
Compliance:cGMP Rx grade
Format:Daily strip 30-90
Rx Only Chronic Use Annex 1 Required
ANTIBIOTIC

Antibiotic Eye Drops

ANTI-INFECTIVE · POST-SURGICAL

Moxifloxacin, ofloxacin, ciprofloxacin, tobramycin antibiotics for bacterial conjunctivitis, post-cataract surgery, post-LASIK infection prevention.

Volume:0.5-1ml per dose
Production:300-350/min
Compliance:cGMP + EU Annex 1
Use Period:7-14 days treatment
Post-Surgical Required FDA PAI Ready Sterile Critical
ALLERGY

Allergy Eye Drops

ANTIHISTAMINE · MAST CELL STABILIZERS

Olopatadine, ketotifen, cromolyn sodium, azelastine for seasonal allergic conjunctivitis. Preservative-free critical for sensitive allergic eyes.

Volume:0.4-0.5ml per dose
Production:350-400/min
Format:OTC strip / Rx pack
Seasonal:30-60 day supply
OTC + Rx Variants Sensitive Eye Safe Seasonal Volume
POST-SURGICAL

Post-Surgical Eye Care

CATARACT · LASIK · GLAUCOMA SURGERY

Steroidal anti-inflammatories (prednisolone, dexamethasone), NSAIDs (ketorolac, bromfenac), antibiotic combinations for post-operative care.

Volume:0.3-0.5ml per dose
Production:300-380/min
Compliance:FDA mandates unit-dose
Pack Size:14-30 day supply
Hospital Standard FDA Required Format Preservative-Free Critical
PEDIATRIC

Pediatric Eye Drops

CHILDREN · INFANTS · NEONATES

Pediatric formulations for conjunctivitis, blocked tear ducts, allergies. Children's eyes especially vulnerable to BAK preservative damage.

Volume:0.3-0.4ml per dose
Production:350-400/min
Safety:Child-safe blister
Format:Single dose strips
Pediatric Safe Hospital Use CR Compliant

Aseptic 8-Step Eye Drops Packaging Process

Validated under EU GMP Annex 1 (2022) and FDA Aseptic Processing Guide

01

VHP Decontamination

Vaporized hydrogen peroxide cycle achieves 6-log sporicidal reduction in isolator before production.

PRE-GRADE A
02

Sterile Film Loading

Pre-sterilized PVC/Aclar/COC forming film loaded under Grade A air supply with material verification.

GRADE A
03

Aseptic Cavity Forming

Validated thermoforming creates ophthalmic blister cavities under continuous Grade A protection.

GRADE A
04

0.22μm Sterile Filtration

Eye drop solution sterile-filtered through 0.22μm membrane immediately before filling. Bubble point tested.

CCP-1
05

Precision Aseptic Filling

Servo micro-pumps fill 0.3-1ml at ±1% accuracy. Photoelectric verification per cavity. Continuous particle monitoring.

CCP-2 — SAL
06

Heat Sealing

Aluminum foil lidding heat-sealed at validated temp/pressure. CCI integrity verified per USP <1207>.

CCP-3 — CCI
07

Serialization & Coding

Lot number, expiry date, unique ID printed for full Track & Trace per DSCSA / EU FMD.

SERIALIZATION
08

100% Vision Inspection

Automated AI inspection rejects any non-conforming blisters. 21 CFR Part 11 audit trail per reject.

QC RELEASE

HIJ Eye Drops Blister Machine — Specifications

Sterile ophthalmic-grade engineering parameters

Parameter Specification Standard / Notes
⚙️ Production Performance
Production Speed300-400 units/minSterile validated operation
High-Speed OptionUp to 600 units/minMulti-cavity tooling
Daily Output (8h)144,000-192,000 dosesSterile aseptic batch
Filling Volume0.3-1ml per cavityCustom range possible
Filling Accuracy±1%Exceeds USP <905>
Repeatability RSD≤ 0.5%Per ICH Q2(R1)
🔬 Sterile Filling System
Cleanroom ClassClass 100 / ISO 5EU GMP Grade A
Barrier ConfigurationRABS / IsolatorCustomer choice
HEPA FiltrationH14 (99.995% @ 0.3μm)Triple stage
VHP Decontamination≤45 min cycle6-log sporicidal
Sterile Filtration0.22μm membraneBubble point tested
Particle MonitoringContinuous viable + non-viablePer Annex 1 (2022)
Aseptic Process SimMedia Fill compatibleFDA APG ready
🌡️ Liquid Handling System
Drug Solution TankSS 316L jacketedElectropolished Ra ≤ 0.4μm
Tank Capacity10L / 20L / 50LCustomer specified
Temperature Control2-30°C ±0.5°CCold chain compatible
Filling MethodServo micro-volumetricPeristaltic for biologics
pH Compatibility3-9Most ophthalmic formulations
CIP/SIPStandard (recommended)FDA cleaning validation
📐 Forming & Sealing
Max Forming Area120 × 80 mmLarger area optional
Forming Depth5-15mmPer cavity volume
Forming MaterialPVC, Aclar, COC, COPPharma-grade certified
Lidding FoilAluminum 20-30μmEasy peel-off design
Sealing TechnologyHeat seal validated±2°C precision
CCI CompatibilityYesUSP <1207> methods
💻 Control & Compliance
PLC SystemSiemens S7-1500FFailsafe certified
HMI Touchscreen15" Siemens TP1500Multi-language
21 CFR Part 11Full compliancee-records, e-sigs, audit trail
EU GMP Annex 11CompliantComputerized systems
Data IntegrityALCOA+ principlesFDA inspection ready
OPC-UA / MES IntegrationStandardERP ready
🔌 Power & Installation
Power Supply380V / 50Hz / 3-phase110V/220V custom
Total Power8.5 kWWith isolator
Compressed Air0.6-0.8 MPa pharma-gradeOil-free, dry, sterile
Machine Dimensions3000×1200×2200 mmL×W×H w/ isolator
Net Weight2,200 kgSS 304/316L frame
✅ Validation & Documentation
DQ/IQ/OQ/PQComplete package includedPre-approval inspection ready
Aseptic Process SimMedia Fill protocols≤1/5,000-10,000 units
CCI TestingUSP <1207> methodsHelium leak / dye ingress
Sterility TestingUSP <71> protocols14-day incubation
Particulate MatterUSP <788> protocolsLight obscuration
FAT/SAT ReportsWitnessed availableCustomer present

Need Annex 1 Validation Package?

Get DQ/IQ/OQ/PQ + Aseptic Process Simulation + CCI testing protocols

Request Annex 1 Documents

Why Ophthalmic Manufacturers Choose HIJ

Specialized expertise in sterile unit-dose eye drops packaging

Sterile Engineering DNA

Designed for aseptic processing from day one. Class 100 ISO 5 architecture, not retrofit. Annex 1 (2022) compliant out of the box.

Annex 1 Native

Preservative-Free Specialist

Validated for BAK-free, EDTA-free formulations. Each unit-dose maintains 24-month sterility without any preservatives.

PF Validated

Aseptic Process Simulation

Media Fill protocols included. Validated to ≤1 contaminated unit per 5,000-10,000 unit fill per FDA Aseptic Processing Guide.

FDA APG Ready

USP Standards Coverage

USP <771> ophthalmic preparations, USP <1207> CCI testing, USP <788> particulates, USP <71> sterility — all protocol-ready.

Full USP Suite

Forester's Pharma Expertise

20+ years pharmaceutical machinery. Has commissioned ophthalmic lines in India, Egypt, Brazil, Vietnam, Bangladesh, and EU.

100+ pharma factories

Smart Pricing for Sterile

European-grade isolator engineering at 30-40% below European pricing. Same Siemens/Schneider components, better value.

30-40% saving

📜 Regulatory Standards for Ophthalmic Blister Packaging Equipment

Sterile ophthalmic blister packaging equipment must comply with the most stringent pharmaceutical regulations due to the eye being a sensitive sterile route of administration. HIJ Machinery's eye drops blister packaging machines are engineered to meet all major international ophthalmic standards:

EU GMP Annex 1 (2022) Manufacture of sterile medicinal products — current revision with CCS requirement
FDA 21 CFR Parts 210 & 211 U.S. Current Good Manufacturing Practice for finished pharmaceuticals
FDA 21 CFR Part 11 Electronic records and electronic signatures regulation
USP <771> Ophthalmic Preparations U.S. Pharmacopoeia ophthalmic dosage form standards
USP <1207> CCI Testing Container closure integrity for sterile pharmaceutical products
USP <788> Particulate Matter Light obscuration testing for ophthalmic injections/solutions
USP <71> Sterility Testing Direct inoculation and membrane filtration sterility methods
USP <905> Uniformity Uniformity of dosage units for unit-dose ophthalmic products
WHO TRS 961 + 986 WHO good manufacturing practices and validation guidelines
FDA Aseptic Processing Guide Sterile drug products produced by aseptic processing (2004)
ICH Q7, Q8, Q9, Q10 International harmonized GMP and quality risk management
EP 5.1.1 Sterility Methods European Pharmacopoeia methods of preparation of sterile products

Sterile ophthalmic blister packaging requires a Class 100 (ISO 5) Grade A environment per EU GMP Annex 1, with continuous viable and non-viable particle monitoring, integrated barrier systems (RABS or isolator), HEPA filtration (H14 minimum, 99.995% efficiency at 0.3μm), and Aseptic Process Simulation (Media Fill) qualification. HIJ machines are designed to meet all these requirements out of the box, with full validation documentation package (DQ/IQ/OQ/PQ + Aseptic Process Simulation + CCI testing) included with every machine.

Source Information HIJ Machinery (Wenzhou) — Sterile pharmaceutical packaging machinery manufacturer
Specialization: Eye drops blister packaging, 0.3-1ml unit doses, Class 100 ISO 5 compatible
Compliance: EU GMP Annex 1 (2022), cGMP 21 CFR 210/211, USP <771>, USP <1207>
Founder: Forester Xiang, 20+ years pharmaceutical machinery, 100+ regulated factories
Website: https://hijpackingmachine.com
Contact: [email protected] | WhatsApp: +86 13868822120
👁️ STERILE OPHTHALMIC CONSULTATION

Ready for Your Sterile Eye Drops Line?

Join 50+ ophthalmic manufacturers who trust HIJ for unit-dose preservative-free packaging

50+ Ophthalmic Lines
60+ Countries
20+ Years Pharma
Annex 1 (2022) Ready

Annex 1 Validation Pack

DQ/IQ/OQ/PQ + Aseptic Process Simulation + CCI testing protocols for FDA/EMA/WHO inspections.

  • DQ/IQ/OQ/PQ protocols
  • Media Fill protocols (APS)
  • USP <1207> CCI testing
  • Annex 1 (2022) compliance
Request Annex 1 Docs

Send Eye Drop Sample

Free sterile filling test with your ophthalmic formulation. Full Aseptic Process Simulation report.

  • Free sterile filling trial
  • Viscosity & accuracy report
  • CCI integrity test
  • Media Fill compatibility
Schedule Sample Test
NDA Standard — Your formulation stays confidential
24h Response — Sterile engineers M-F 8AM-8PM GMT+8
Forester's Team — 20+ years pharma expertise

Frequently Asked Questions

Sterile ophthalmic packaging answers for pharma buyers

Can the machine package preservative-free eye drops?
Yes. HIJ eye drops blister machines with isolator/RABS configuration enable preservative-free single-dose ophthalmic packaging. The Class 100 (ISO 5) sterile filling environment with HEPA filtration eliminates the need for preservatives like BAK (benzalkonium chloride) that cause irritation in 30% of users. Each blister maintains sterility for 24 months without any preservatives.
Is the machine compliant with EU GMP Annex 1 (2022 revision)?
Yes. HIJ eye drops blister machines fully comply with EU GMP Annex 1 (2022 revision) for sterile medicinal products manufacturing. Includes Contamination Control Strategy (CCS) compatibility, Grade A air supply over open product, continuous viable and non-viable particle monitoring, and integrated barrier systems (RABS or isolator). Validation documentation package includes Annex 1 compliance evidence.
What is the production capacity for unit dose eye drops?
HIJ eye drops blister machines produce 300-400 unit-dose ophthalmic blisters per minute, depending on cavity count. Daily output: 144,000-192,000 sterile eye drop doses per 8-hour shift. High-speed configurations available up to 600 units/min for large pharmaceutical manufacturers. Multi-cavity tooling (up to 12 cavities) maximizes output.
How accurate is filling for 0.3-1ml eye drop doses?
HIJ achieves ±1% filling accuracy across the 0.3-1ml ophthalmic range. Servo-driven micro-volumetric or peristaltic pumps with photoelectric verification ensure each unit dose meets USP <905> uniformity of dosage units requirements. Repeatability RSD ≤ 0.5% per ICH Q2(R1). This precision exceeds FDA, EMA, and WHO requirements for ophthalmic unit-dose products.
What sterilization methods are supported?
HIJ machines support multiple aseptic processing approaches: terminal sterilization compatible blister formats (autoclave-resistant materials), aseptic filling under Class 100/ISO 5 with sterile-filtered drug solution (0.22μm), VHP (vaporized hydrogen peroxide) decontamination of isolator achieving 6-log sporicidal reduction, and gamma-compatible packaging materials. Aseptic Process Simulation (Media Fill) protocols included.
What ophthalmic formulations are compatible?
HIJ machines package: artificial tears (CMC, hyaluronic acid, HPMC), allergy eye drops (antihistamines, mast cell stabilizers), glaucoma medications (prostaglandins, beta-blockers, carbonic anhydrase inhibitors), antibiotic eye drops (moxifloxacin, ofloxacin), anti-inflammatory drops (NSAIDs, steroids), dry eye treatments (cyclosporine, lifitegrast), pediatric eye drops, and post-surgical eye drops. Volume range 0.3-1ml. pH range 3-9 compatible.
What validation documentation is included?
Complete validation package: DQ/IQ/OQ/PQ protocols, Aseptic Process Simulation (Media Fill) protocols per FDA Aseptic Processing Guide, Container Closure Integrity (CCI) testing protocols per USP <1207>, environmental monitoring program, sterility testing per USP <71>, particulate matter testing per USP <788>, and FAT/SAT documentation. All audit-ready for FDA pre-approval inspection (PAI), EMA, and WHO prequalification.
What is the price range for sterile eye drops blister machines?
Price ranges (FOB Wenzhou):
Standard Class 100 compatible with RABS: USD 120,000-180,000
Full isolator configuration with VHP decontamination: USD 200,000-280,000
High-speed multi-cavity (600 units/min): USD 250,000-380,000
All prices include CE certification, complete validation package, EU GMP Annex 1 documentation, and one mold format. ROI typically 18-30 months for ophthalmic manufacturers based on premium pricing of preservative-free products.
How does Aseptic Process Simulation (Media Fill) work?
Media Fill validates aseptic processing capability by replacing the drug solution with sterile microbiological growth media (e.g., Tryptic Soy Broth) and running the machine under normal production conditions. Filled units are incubated 14 days, then inspected for contamination. Acceptance criterion: ≤1 contaminated unit per 5,000-10,000 unit fill per FDA Aseptic Processing Guide. HIJ provides Media Fill protocols, training, and on-site execution support.
Can HIJ eye drops machines pass FDA pre-approval inspection?
Yes. HIJ ophthalmic machines are designed to pass FDA pre-approval inspections (PAI), EMA inspections, and WHO prequalification audits. Multiple HIJ-equipped ophthalmic facilities have successfully passed regulatory inspections. We provide pre-inspection support including documentation review, mock audit, inspector Q&A preparation, and on-site engineer support during actual inspections.
What is the lead time for sterile eye drops blister delivery?
Standard lead time for sterile ophthalmic machines: 16-22 weeks from order confirmation to FOB Wenzhou. Includes manufacturing, isolator integration (if specified), validation documentation preparation, FAT execution with VHP cycle validation, and pre-shipment inspection. Full isolator configurations: 20-26 weeks. Shipping to most ports adds 2-4 weeks. Site preparation and SAT add 4-8 weeks for total project timeline.
Can I send my eye drop sample for sterile filling test?
Yes. Free sterile filling trials available at HIJ Wenzhou facility. Send 500ml-2L of your formulation under NDA. We test: viscosity behavior, fill accuracy, sterile filtration compatibility (0.22μm), CCI integrity per USP <1207>, and sealing parameters. Trial includes limited Aseptic Process Simulation with growth media fill. Results delivered as comprehensive report with video documentation. Typical turnaround: 14-21 days.

Have Specific Annex 1 Questions?

Talk to Forester's sterile processing team — 24h response

Talk to Sterile Expert

Let's Design Your Production Line

Share your requirements and I'll personally craft a solution that maximizes your efficiency and profitability.